
Submission of safety information for cosmetics raw materials will soon be standardized according to the CSAR and Measures for the Admin...

This webinar provides insights on how to avoid animal testing in China for cosmetics and stay compliant with local regulations.

Guidelines for medical device registration in China have new development plans released in April 2023 - 108 will be implemented and revised

"China DMF of API, Excipient & Packaging Materials: Market & Regulatory" will be an hour webinar session covering the process and trends...

Pre-Phase III drug clinical trial meeting guidelines have been released by the NMPA CDE for trial implementation as of March 22, 2023.

China’s Center for Drug Evaluation has released new Guidelines for Information on China Chemical Drug Instructions and Labels.

China medical device market eRPS data error correction matters will be incorporated into the business scope on April 20, 2023.

China medical device sampling inspection plan for 2023 covers 68 products including electronic endoscopes, medical oxygen concentrators etc.

China radio frequency beauty devices have new technical review guidelines issued to ensure that products are safe and effective

China’s NMPA issues further explanations on how to interpret and implement GB9706.1-2020 standards for medical electrical equipment

China releases a whitepaper on its AI medical device market. The AI medical device industry is becoming a new growth driver.

Oral solid dosage continuous manufacturing technical guidelines have been issued by the China CDE on Mar. 21, 2023, for trial implementation

Ultrasound soft tissue surgical equipment in China have new technical review guidelines amended for registration dossier preparation

Chinese Pharmacopoeia 2020 edition was translated into English and officially published by the Chinese CPC on March 14, 2023.

China cosmetic e-commerce operators and the distribution of cosmetics will be subject to new rules on September 1, 2023.

China medical device industry standards March 2023 update covers 20 standards released by the NMPA for manufacturers to comply with.

Hong Kong drug and medical device registrations are increasingly in demand. Join the Cisema team for a recap of latest policy updates.

Cosmetic ingredient safety information update in China has now a longer transition period for cosmetic and raw material manufacturers

China’s IVD reagent classification catalogue has been revised and reissued for industry comment. The deadline for submission is Apr. 12, 2023

GB9706 standards for medical electrical equipment have new NMPA guidelines to help applicants determine the implementation dates
And discover how we can support you.